Extract of Schisandra chinensis fruit protects against metabolic dysfunction in high‐fat diet induced obese mice via FXR activation

Schisandra chinensis fruit has been shown to restore carbohydrate‐ and lipid‐metabolic disorders and has anti‐hepatotoxicity and anti‐hepatitis activities. However, the molecular targets mediating the pharmacological properties of S . chinensis fruit have not been clarified. Here, we assayed the effects of S . chinensis fruit ethanol extract (SCE) on farnesoid X receptor (FXR) transactivity. The pharmacological effects of SCE (1 g/100 g diet) were assessed in high‐fat diet (HFD)‐fed C57BL/6 mice and ob/ob mice. The FXR and Fgf15 signalling pathways were evaluated by FXR silencing, ELISA, Western blot and RT‐PCR analyses. The results showed that SCE treatment increased FXR transcription activity and improved obesity, hypercholesteremia and fatty liver in HFD‐fed mice, while it had limited effects on ob/ob mice. Our study suggests that SCE treatment may improve HFD‐induced metabolic disorders through pharmacological activation of FXR/Fgf15 signalling, and such beneficial effects of SCE may require leptin participation.